Guardian Capital (Canada)’s Merus Labs International Inc. MSLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-1,171,900
Closed -$1.09M 216
2017
Q1
$1.09M Sell
1,171,900
-6,600
-0.6% -$5.69K 0.02% 144
2016
Q4
$1.02M Hold
1,178,500
0.02% 140
2016
Q3
$1.19M Sell
1,178,500
-29,900
-2% -$33.7K 0.02% 131
2016
Q2
$1.53M Buy
1,208,400
+210,500
+21% +$294K 0.03% 127
2016
Q1
$1.49M Buy
997,900
+90,000
+10% +$125K 0.03% 124
2015
Q4
$1.5M Buy
907,900
+19,800
+2% +$26.9K 0.03% 124
2015
Q3
$1.14M Buy
888,100
+305,200
+52% +$606K 0.02% 130
2015
Q2
$1.37M Sell
582,900
-37,300
-6% -$90.5K 0.02% 136
2015
Q1
$1.31M Sell
620,200
-166,200
-21% -$306K 0.02% 135
2014
Q4
$1.29M Hold
786,400
0.02% 125
2014
Q3
$1.17M Hold
786,400
0.02% 131
2014
Q2
$1.73M Hold
786,400
0.03% 121
2014
Q1
$1.19M Buy
+786,400
New +$1.12M 0.02% 128

Other funds holding MSLI

Guardian Capital (Canada)'s MSLI Position: Q2 2017 in Review

Guardian Capital (Canada) sold out of Merus Labs International Inc. (MSLI) in Q2 2017, closing a stake of 1,171,900 shares — an estimated $1.09M sold.

Guardian Capital (Canada) first reported a position in MSLI in Q1 2014 and held it in 13 quarters. The position peaked at $1.73M in Q2 2014. 24 funds tracked by Wall St. Rank hold MSLI as of Q2 2017.

  • Guardian Capital (Canada) reported no remaining Merus Labs International Inc. position as of Q2 2017 after selling out during the quarter.
  • Guardian Capital (Canada) sold 1,171,900 Merus Labs International Inc. shares in Q2 2017, an estimated $1.09M.
  • Guardian Capital (Canada) first reported a position in Merus Labs International Inc. in Q1 2014 and held it in 13 quarters.
  • Guardian Capital (Canada)'s Merus Labs International Inc. position peaked at $1.73M in Q2 2014.
  • 24 funds tracked by Wall St. Rank held Merus Labs International Inc. as of Q2 2017.

Based on Guardian Capital (Canada)'s 13F filing for Q2 2017, filed 14 Aug 2017.